Sanofi Drug for Rare Blood Disease Is Heading to Recordati for $825M
Sanofi’s Enjaymo, the one permitted drug remedy for a uncommon and debilitating blood dysfunction, is being acquired by Recordati in ...
Tag: 825M
Discover the latest health news, expert insights, and practical advice on nutrition, fitness, mental health, and more at Arafat Concierge Wellness. Stay informed, stay healthy, and take charge of your well-being today.